Presentations to highlight hypothermic oxygenated perfusion (HOPE) with VitaSmart™ in liver transplants, including pediatric patients and partial grafts.
DULUTH, Ga., April 28, 2026 /PRNewswire/ — Bridge to Life™ Ltd, a global innovator in organ preservation solutions and perfusion technology, today announced the acceptance of 12 abstracts (five oral, including one plenary session presentation, and seven poster presentations, including one late-breaking) at the 2026 International Liver Transplantation Society (ILTS) conference. The conference is scheduled to take place in Geneva, Switzerland, from May 6-9, 2026.
All times are expressed in Central European Summer Time (CEST), UTC+2.
Oral Abstract Presentations
Abstract Title: “Donor Serum FMN Reflects Mitochondrial Injury and Predicts Outcomes After Liver Transplantation: A Metabolic Donor Signature of Graft Quality”Session Title: Simultaneous Oral Session 4: Selection Criteria, Patient Selection, Organ Allocation
Date/time: Thursday, May 7, 2026 from 1:45 – 3:00 PM
Presenter: Fatma Selin Yildirim, Cleveland Clinic
Abstract Title: “Prolonged HOPE Preserves Mitochondrial Function and Enables Logistical Flexibility in Liver Transplantation”Session Title: Simultaneous Oral Session 5: Fundamental Science, Translational Research, and Tolerance Induction 1
Date/time: Thursday, May 7, 2026 from 3:15 – 4:30 PM
Presenter: Omer Faruk Karakaya, Cleveland Clinic
Abstract Title: “Perfusate Microbiology Before and After Hypothermic Oxygenated Perfusion: A Missing Piece in Graft Evaluation”Session Title: Simultaneous Oral Session 7: Immunosuppression and Infection
Date/time: Friday, May 8, 2026, 10:45 AM – 12:00 PM
Presenter: Marco Pascale, Policlinico Universitario Agostino Gemelli
Abstract Title: “A Donor Risk Factor-Inclusive Machine Learning Equation for Predicting Cholangiocarcinoma Recurrence After Liver Transplantation”Session Title: Simultaneous Oral Session 13: Comorbidities and Outcomes of Liver Transplantation II
Date/time: Friday, May 8, 2026, 2:45 – 4:00 PM
Presenter: Laura Batista De Oliveira, Cleveland Clinic
Abstract Title: “Prolonged Hypothermic Oxygenated Perfusion in Pediatric Partial Liver Grafts: A Bicentric Experience in the UK”Session Title: Plenary Session 2 Abstracts
Date/time: Saturday, May 9, 2026, 8:00 – 9:15 AM
Presenter: Alba Bueno, Birmingham Children’s Hospital
Poster Presentations
Late-breaking Abstract:
Poster Title: Sequential Normothermic Regional Perfusion and Hypothermic Oxygenated Machine Perfusion in Liver Grafts from Donors After Circulatory Death Can Protect Against Ischemic Cholangiopathy
Presenter: Sergio Cortese, Gregorio Maranon University Hospital
Poster Title: Three Years of Experience in HOPE Utilization in a Single Center
Presenter: Dora Gomez Pasantes, A Coruna University Hospital Complex
Poster Title: “Hypothermic Oxygenated Perfusion (HOPE) Expands Donor Acceptance Criteria with Optimal Outcomes: A Multicenter Matched-Cohort Study”
Speaker: Luis Secanella, Bellvitge University Hospital
Poster Title: “Recovering the Discarded Livers Using HOPE”
Speaker: Mireia Caralt, Vall d’Hebron University Hospital
Poster Title: “Impact of HOPE on Very Elderly DCD Livers (>70 years): Insights from a Belgian Bi-Centeric Experience”
Speaker: Maxime Foguenne, Saint-Luc University Clinics
Poster Title: “Preliminary Single-Center Experience with Hypothermic Machine Perfusion in Liver Transplantation Using Extended-Criteria Donors”
Speaker: Oscar Caso, Doce de Octubre University Hospital
Poster Title: “Perfusate-Derived Biochemical Markers During Hypothermic Oxygenated Perfusion Predict Early Allograft Dysfunction After Liver Transplantation”
Speaker: Marco Pascale, Policlinico Universitario Agostino Gemelli
“Bridge to Life” Symposium
Bridge to Life will also sponsor a lunchtime symposium, “The Future of Machine Perfusion: Combining Strategies, Optimizing Care, and Expanding Possibilities”, on May 7, 12:45 – 1:45 PM CEST (UTC+2) at Palexpo 1 Convention Center, Room K.
Speakers include:
- Damiano Patrono, MD, PhD, Citta della Salute e della Scienza University Hospital, Turin
- Rebeca Mateos, MD, University Hospitals Birmingham
- Andrea Schlegel, MD, MBA, Cleveland Clinic Ohio
About Bridge to Life™ Ltd
Bridge to Life™ Ltd is a market leader in organ preservation solutions, offering leading products such as Belzer UW®, EasiSlush®, and the VitaSmart™ hypothermic oxygenated perfusion system. Focusing on product quality, innovation, and accessibility, the company serves key transplant centers and organ procurement organizations worldwide, with whom it partners.
Logo – View here
